NCT02412943View on ClinicalTrials.gov

Pappalysin 2 (PAPP-A2) Enzyme Replacement

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Short Stature, Idiopathic
Interventions
OTHER

Fresh Frozen Plasma

Liquid portion of human blood that was centrifuged, separated, and frozen solid within 6 hours of collection

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02412943 - Pappalysin 2 (PAPP-A2) Enzyme Replacement | Biotech Hunter | Biotech Hunter